Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The RET proto-oncogene in human cancers

Abstract

The activation of the RET proto-oncogene contributes to the development of human cancers in two different ways. Somatic rearrangements of RET with a variety of activating genes, which contribute to unscheduled expression and constitutive dimerization of the chimeric RET/PTC oncoproteins in thyroid follicular cells, are frequently found in radiation-induced papillary thyroid carcinomas. Germ-line mutations, mainly point mutations, that lead to constitutive activation of RET tyrosine kinase activity are responsible for the development of the inherited cancer syndrome, multiple endocrine neoplasia type 2. There appears to be a correlation between specific types of RET mutation and clinical phenotypes of the cancers involved. The biological effects and the signaling pathways induced by different forms of RET activation have been investigated in a variety of cultured cells as well as in genetically engineered animal models. The identification of RET mutations in most MEN 2 families (95%) has translated into improved care for MEN 2 patients. However, further investigation of the signaling pathways contributing to tumorigenesis in relevant tissues will eventually help us to develop novel strategies to prevent or to treat human papillary thyroid carcinomas, MEN 2 disease, as well as the sporadic cancers relevant to MEN 2 disease.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Acton DS, Velthuyzen D, Lips CJ and Hoppener JW. . 2000 Oncogene 19: 3121–3125.

  • Airaksinen MS, Titievsky A and Saarma M. . 1999 Mol. Cell. Neurosci. 3: 313–325.

  • Asai N, Iwashita T, Murakami H, Takanari H, Ohmori K, Ichihara M and Takahashi M. . 1999 Biochem. Biophys. Res. Commun. 255: 587–590.

  • Asai N, Murakami H, Iwashita T and Takahashi M. . 1996 J. Biol. Chem. 271: 17644–17649.

  • Baloh RH, Enomoto H, Johnson Jr EM and Milbrandt J. . 2000 Curr. Opin. Neurobiol. 10: 103–110.

  • Bartsch DK, Hasse C, Schug C, Barth P, Rothmund M and Hoppner W. . 2000 Exp. Clin. Endocrinol. Diabetes 108: 128–132.

  • Bocciardi R, Mograbi B, Pasini B, Borrello MG, Pierotti MA, Bourget I, Fischer S, Romeo G and Rossi B. . 1997 Oncogene 15: 2257–2265.

  • Bond JA, Wyllie FS, Rowson J, Radulescu A and Wynford-Thomas D. . 1994 Oncogene 9: 281–290.

  • Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT and Pierotti MA. . 1996 Mol. Cell. Biol. 16: (5) 2151–2163.

  • Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M and Suarez HG. . 1997 Oncogene 15: 1263–1273.

  • Califano D, D'Alessio A, Colucci-D'Amato GL, De Vita G, Monaco C, Santelli G, Di Fiore PP, Vecchio G, Fusco A, Santoro M and De Franciscis V. . 1996 Proc. Natl. Acad. Sci. USA 93: 7933–7937.

  • Califano D, Rizzo C, D'Alessio A, Colucci-D'Amato GL, Cali G, Bartoli PC, Santelli G, Vecchio G and de Franciscis V. . 2000 J. Biol. Chem. 275: 19297–19305.

  • Chappuis-Flament S, Pasini A, De Vita G, Segouffin-Cariou C, Fusco A, Attie T, Lenoir GM, Santoro M and Billaud M. . 1998 Oncogene 17: 2851–2861.

  • Cho J-Y, Sagartz JE, Capen CC, Mazzaferri EL and Jhiang SM. . 1999 Oncogene 18: 3659–3665.

  • Cinti R, Yin L, Ilc K, Berger N, Basolo F, Cuccato S, Giannini R, Torre G, Miccoli P, Amati P, Romeo G and Corvi R. . 2000 Cytogenet. Cell. Genet. 88: 56–61.

  • Colucci-D'Amato GL, D'Alessio A, Califano D, Cali G, Rizzo C, Nitsch L, Santelli G and de Franciscis V. . 2000 J. Biol. Chem. 275: 19306–19314.

  • De Vita G, Zannini M, Cirafici AM, Melillo RM, Di Lauro R, Fusco A and Santoro M. . 1998 Cell. Growth Differ. 9: 97–103.

  • Durick K, Gill GN and Taylor SS. . 1998 Mol. Cell. Biol. 18: 2298–2308.

  • Durick K, Wu R-Y, Gill GN and Taylor SS. . 1996 J. Biol. Chem. 271: 12691–12694.

  • Eng C. . 1999 J. Clin. Oncol. 17: 380–393.

  • Fischer AH, Bond JA, Taysavang P, Battles OE and Wynford-Thomas D. . 1998 Am. J. Pathol. 153: 1443–1450.

  • Giannini R, Salvatore G, Monaco C, Sferratore F, Pollina L, Pacini F, Basolo F, Fusco A and Santoro M. . 2000 Int. J. Oncol. 16: 485–489.

  • Grieco D, Santoro M, Dathan NA and Fusco A. . 1995 Oncogene 11: 113–117.

  • Ito S, Iwashita T, Asai N, Murakami H, Iwata Y, Sobue G and Takahashi M. . 1997 Cancer Res. 57: 2870–282.

  • Itoh F, Ishizaka Y, Tahira T, Ikeda I, Imai K, Yachi A, Sugimura T and Nagao M. . 1989 Tumor Res. 24: 1–13.

  • Iwashita T, Asai N, Murakami H, Matsuyama M and Takahashi M. . 1996 Oncogene 12: 481–487.

  • Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, Iwata Y, Kawai K, Asai M, Kurokawa K, Kajita H and Takahashi M. . 1999 Oncogene 18: 3919–3922.

  • Iwashita T, Murakami H, Kurokawa K, Kawai K, Miyauchi A, Futami H, Qiao S, Ichihara M and Takahashi M. . 2000 Biochem. Biophys. Res. Commun. 268: 804–808.

  • Jhiang SM and Mazzaferri EL. . 1994 J. Lab. Clin. Med. 123: 331–337.

  • Jhiang SM, Caruso DR, Gilmore E, Ishizaka Y, Tahira T, Nagano M, Chiu IM and Mazzaferri EL. . 1992 Oncogene 7: 1331–1337.

  • Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho J-Y, Xing S and Ledent C. . 1996 Endocrinology 137: 375–378.

  • Klugbauer S and Rabes HM. . 1999 Oncogene 18: 4388–4393.

  • Klugbauer S, Lengfelder E, Demidchik EP and Rabes HM. . 1995 Oncogene 11: 2459–2467.

  • Krijger RR, Harst EV, Muletta-Feurer S, Bruining HA, Lamberts SW, Dinjens WN, Roth J, Heitz PU and Komminoth P. . 2000 J. Pathol. 191: 264–268.

  • Liu X, Vega QC, Decker RA, Pandey A, Worby CA and Dixon JE. . 1996 J. Biol. Chem. 271: 5309–5312.

  • Michiels FM, Chappuis S, Caillou B, Pasini A, Talbot M, Monier R, Lenoir GM, Feunteun J and Billaud M. . 1997 Proc. Natl. Acad. Sci. USA 94: 3330–3335.

  • Mizuno T, Iwamoto KS, Kyoizumi S, Nagamura H, Shinohara T, Koyama K, Seyama T and Hamatani K. . 2000 Oncogene 19: 438–443.

  • Murakami H, Iwashita T, Asai N, Shimono Y, Iwata Y, Kawai K and Takahashi M. . 1999 Biochem. Biophys. Res. Commun. 262: 68–75.

  • Nakata T, Kitamura Y, Shimizu K, Tanaka S, Fujimori M, Yokoyama S, Ito K and Emi M. . 1999 Genes Chrom. Cancer 25: 97–103.

  • Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H and Fagin JA. . 1997 Cancer Res. 57: 1690–1694.

  • Pachnis V, Mankoo B and Costantini F. . 1993 Development 119: 1005–1017.

  • Pasini A, Geneste O, Legrand P, Schlumberger M, Rossel M, Fournier L, Rudkin BB, Schuffenecker I, Lenoir GM and Billaud M. . 1997 Oncogene 15: 393–402.

  • Pawson T and Scott JD. . 1997 Science 278: 2075–2080.

  • Ponder BA. . 1999 Cancer Res. 59: 1736s–1742s.

  • Powell Jr DJ, Russell J, Nibu K, Li G, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A and Rothstein JL. . 1998 Cancer Res. 58: 5523–5528.

  • Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D and Klugbauer S. . 2000 Clin. Cancer Res. 6: 1093–1103.

  • Romano A, Wong WT, Santoro M, Wirth PJ, Thorgeirsson SS and Di Fiore PP. . 1994 Oncogene 9: 2923–2933.

  • Sagartz JE, Jhiang SM, Tong Q and Capen CC. . 1997 Lab. Invest. 76: 307–318.

  • Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH and Di Fiore PP. . 1995 Science 267: 381–383.

  • Santoro M, Melillo RM, Carlomagno F, Visconti R, De Vita G, Salvatore G, Fusco A and Vecchio G. . 1999 Biochimie 81: 397–402.

  • Santoro M, Melillo RM, Grieco M, Berlingieri MT, Vecchio G and Fusco A. . 1993 Cell Growth Differ. 4: 77–84.

  • Santoro M, Wong WT, Aroca P, Santos E, Matoskova B, Grieco M, Fusco A and Di Fiore PP. . 1994 Mol. Cell. Biol. 14: 663–675.

  • Schlessinger J and Ullrich A. . 1992 Neuron 9: 383–391.

  • Schuchardt A, D'Agatl V, Larsson-Blomberg L, Costantini F and Pachnis V. . 1994 Nature 367: 380–383.

  • Segouffin-Cariou C and Billaud M. . 2000 J. Biol. Chem. 275: 3568–3576.

  • Smida J, Salassidis K, Hieber L, Zitzelsberger H, Kellerer AM, Demidchik EP, Negele T, Spelsberg F, Lengfelder E, Werner M and Bauchinger M. . 1999 Int. J. Cancer 80: 32–38.

  • Smith-Hicks CL, Sizer KC, Powers JF, Tischler AS and Costantini F. . 2000 EMBO J. 19: 612–622.

  • Soares P, Fonseca E, Wynford-Thomas D and Sobrinho-Simoes M. . 1998 J. Pathol. 185: 71–78.

  • Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML and Fusco A. . 1998 Clin. Cancer Res. 4: 287–294.

  • Tessitore A, Sinisi AA, Pasquali D, Cardone M, Vitale D, Bellastella A and Colantuoni V. . 1999 J. Clin. Endocrinol. Metab. 84: 3522–3527.

  • Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M and Vecchio G. . 1999 J. Clin. Endocrinol. Metab. 84: 4232–4238.

  • Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M and Asai J. . 1995 Oncogene 10: 191–198.

  • Uchino S, Noguchi S, Yamashita H, Sato M, Adachi M, Yamashita H, Watanabe S, Ohshima A, Mitsuyama S, Iwashita T and Takahashi M. . 1999 Jpn. J. Cancer Res. 90: 1231–1237.

  • van Puijenbroek A, van Weering DHJ, van den Brink CE, Bos JL, van der Saag PT, de Laat SW and den Hertog J. . 1997 Oncogene 14: 1147–1157.

  • van Weering DHJ and Bos JL. . 1998 Recent Res. Cancer Res. 154: 271–281.

  • van Weering DHJ and Bos JL. . 1997 J. Biol. Chem. 272: 249–254.

  • van Weering DHJ, Medema JP, van Puijenbroek A, Burgering BMT, Baas PD and Bos JL. . 1995 Oncogene 11: 2207–2214.

  • Vega QC, Worby CA, Lechner MS, Dixon JE and Dressler GR. . 1996 Proc. Natl. Acad. Sci. USA 93: 10657–10661.

  • Worby CA, Vega QC, Zhao Y, Chao H-J, Seasholtz AF and Dixon JE. . 1996 J. Biol. Chem. 271: 23619–23622.

  • Xing S, Furminger TL, Tong Q and Jhiang SM. . 1998 J. Biol. Chem. 273: 4909–4914.

  • Xing S, Smanik PA, Oglesbee MJ, Trosko JE, Mazzaferri EL and Jhiang SM. . 1996 Endocrinology 137: 1512–1519.

Download references

Acknowledgements

I would like to acknowledge Tara Buckwalter and Kwon-Yul Ryu for preparation of the figures. Tara Buckwalter and Krista LaPerle critically reviewed this manuscript. This work was supported by a grant from NIH, NCI (CA60074).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jhiang, S. The RET proto-oncogene in human cancers. Oncogene 19, 5590–5597 (2000). https://doi.org/10.1038/sj.onc.1203857

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203857

Keywords

This article is cited by

Search

Quick links